Organization | AUSL della Romagna-RAVENNA

AUSL della Romagna-RAVENNA Report issue

Academic/Hospital Phase 2

Founded: Ravenna Italy (2013)

Organization Overview

First Clinical Trial

2015

NCT02477813

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2021

Timeline

NOW

Alternative names

AUSL ROMAGNA | AUSL Romagna- P.O. di Ravenna | AUSL Romagna Rimini | Oncology Department, PO Ravenna, AUSL della Romagna | UOC Oncologia Medica - PO di Ravenna - AUSL della Romagna-RAVENNA Viale Randi 5 - 48121 Ravenna

Active Ingredients

Drugs in Phase 2 Trials (7)

cabozantinib (cometriq) (1 trial)

capecitabine (xeloda) (1 trial)

cisplatin (platinol) (1 trial)

durvalumab (imfinzi) (1 trial)

pemetrexed (alimta) (1 trial)

temozolomide (temodar) (1 trial)

vinorelbine (navelbine) (1 trial)

Drugs in Other Trials (2)

melatonin (1 trial)

morphine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Lung Neoplasms (Phase 2)

Rectal Neoplasms (Phase 2)

Small Cell Lung Carcinoma (Phase 2)

Overview

Highest Phase: Phase 2
# of Trials: 6
# of Trial APIs: 9